Tempest Therapeutics's total assets for Q1 2025 were $32.16M, a decrease of -22.47% from the previous quarter. TPST total liabilities were $21.03M for the fiscal quarter, a -5.95% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.